SPPI Financial Facts
Total revenues: 38.67MSelling, general and administrative: 22.35M
See Full Income Statement
Additional paid-in capital: 465.37M
Cash and cash equivalents: 160.07M
See Full Balance Sheet
Earnings History for Spectrum Pharmaceuticals (SPPI)
|
Expand Research on SPPI
| Next EPS Date | 3/1/13 *Est. | EPS Growth Rate | +23.5% *Last Qtr. |
|---|---|---|---|
| Average EPS % Beat Rate | +23.8% | Revenue Growth Rate | +35.2% *Last Qtr. |
| Average % Move 1-Wk after EPS | -6.6% |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Estimize EPS/Revs | Gd. | % Since | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
11/7/12  |
 |
Q312 | $0.42 | $0.29 | +$0.13 | $69M | $68.56M | N/A / N/A | N/A | -24.6% | Details |
| 8/8/12 | Q212 | $0.40 | $0.32 | +$0.08 | $68.7M | $63.4M | N/A / N/A | N/A | -37.8% | Details | |
| 4/26/12 |
|
Q112 | $0.40 | $0.27 | +$0.13 | $60M | $56.93M | N/A / N/A | N/A | -23.2% | Details |
| 3/1/12 |
Q411 | $0.24 | $0.31 | -$0.07 | $5.98M | $52.73M | N/A / N/A | N/A | -39.7% | Details | |
| 10/28/11 |
|
Q311 | $0.34 | $0.10 | +$0.24 | $51.02M | $40.17M | N/A / N/A | N/A | -11.8% | Details |
| 8/4/11 |
|
Q211 | $0.12 | $0.15 | -$0.03 | $45.5M | $37.25M | N/A / N/A | N/A | -20.3% | Details |
| 3/10/11 | Q410 | $0.08 | -$0.05 | +$0.13 | $34M | $19.57M | N/A / N/A | N/A | +24.1% | Details |
